[go: up one dir, main page]

Burkovitz et al., 2013 - Google Patents

Computational identification of antigen-binding antibody fragments

Burkovitz et al., 2013

View PDF
Document ID
11396777277105412845
Author
Burkovitz A
Leiderman O
Sela-Culang I
Byk G
Ofran Y
Publication year
Publication venue
The Journal of Immunology

External Links

Continue reading at www.academia.edu (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
    • C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
    • C07K2317/55—Fab or Fab'
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin

Similar Documents

Publication Publication Date Title
Gramespacher et al. Roadmap for optimizing and broadening antibody-based PROTACs for degradation of cell surface proteins
Trier et al. Peptides, antibodies, peptide antibodies and more
Feng et al. Construction and next-generation sequencing analysis of a large phage-displayed VNAR single-domain antibody library from six naive nurse sharks
Sela-Culang et al. The structural basis of antibody-antigen recognition
Kovaleva et al. Shark variable new antigen receptor biologics–a novel technology platform for therapeutic drug development
Yeung et al. Engineering human IgG1 affinity to human neonatal Fc receptor: impact of affinity improvement on pharmacokinetics in primates
Ying et al. Soluble monomeric IgG1 Fc
Marvin et al. Redesigning an antibody fragment for faster association with its antigen
Akiba et al. Thermodynamics of antibody–antigen interaction revealed by mutation analysis of antibody variable regions
Phillips et al. Rate of asparagine deamidation in a monoclonal antibody correlating with hydrogen exchange rate at adjacent downstream residues
Weber et al. A highly functional synthetic phage display library containing over 40 billion human antibody clones
Burkovitz et al. Computational identification of antigen-binding antibody fragments
Rudolf et al. Epitope-specific antibody response to IgE by mimotope immunization
Wang et al. Characterization of pathogenic human monoclonal autoantibodies against GM-CSF
Woods Selection of functional intracellular nanobodies
Gong et al. N-terminal truncation of an isolated human IgG1 CH2 domain significantly increases its stability and aggregation resistance
Souriau et al. New binding specificities derived from Min-23, a small cystine-stabilized peptidic scaffold
Li et al. In vitro affinity maturation of a natural human antibody overcomes a barrier to in vivo affinity maturation
Macpherson et al. Isolation of antigen-specific, disulphide-rich knob domain peptides from bovine antibodies
Gong et al. Shortened engineered human antibody CH2 domains: increased stability and binding to the human neonatal Fc receptor
Gehlsen et al. Pharmacokinetics of engineered human monomeric and dimeric CH2 domains
Rinderknecht et al. Phage-derived fully human monoclonal antibody fragments to human vascular endothelial growth factor-C block its interaction with VEGF receptor-2 and 3
Timmerman et al. A combinatorial approach for the design of complementarity-determining region-derived peptidomimetics with in vitro anti-tumoral activity
Gong et al. Bispecific engineered antibody domains (nanoantibodies) that interact noncompetitively with an HIV-1 neutralizing epitope and FcRn
Murali et al. Structure based antibody-like peptidomimetics